Maternal Biomarkers of Acetaminophen Use and Offspring Attention Deficit Hyperactivity Disorder
- PMID: 29970852
- PMCID: PMC6071105
- DOI: 10.3390/brainsci8070127
Maternal Biomarkers of Acetaminophen Use and Offspring Attention Deficit Hyperactivity Disorder
Abstract
Previous studies have suggested a positive association between self-reported maternal acetaminophen use during pregnancy and risk of attention deficit hyperactivity disorder (ADHD) in offspring. We sought to examine the prospective association between maternal plasma biomarkers of acetaminophen intake and ADHD diagnosis in the offspring. This report analyzed 1180 children enrolled at birth and followed prospectively as part of the Boston Birth Cohort, including 188 with ADHD diagnosis based on electronic medical record review. Maternal biomarkers of acetaminophen intake were measured in plasma samples obtained within 1⁻3 days postpartum. Odds ratios for having ADHD diagnosis or other developmental disorders were estimated using multinomial logistic regression models, adjusting for pertinent covariables. Compared to neurotypical children, we observed significant positive dose-responsive associations with ADHD diagnosis for each maternal acetaminophen biomarker. These dose⁻responsive associations persisted after adjusting for indication of acetaminophen use and other pertinent covariates; and were specific to ADHD, rather than other neurodevelopmental disorders. In the stratified analyses, differential point estimates of the associations were observed across some strata of covariates. However, these differences were not statistically significant. Maternal acetaminophen biomarkers were specifically associated with increased risk of ADHD diagnosis in offspring. Additional clinical and mechanistic investigations are warranted.
Keywords: ADHD; acetaminophen; pregnancy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood.JAMA Psychiatry. 2020 Feb 1;77(2):180-189. doi: 10.1001/jamapsychiatry.2019.3259. JAMA Psychiatry. 2020. PMID: 31664451 Free PMC article.
-
A Prospective Birth Cohort Study on Maternal Cholesterol Levels and Offspring Attention Deficit Hyperactivity Disorder: New Insight on Sex Differences.Brain Sci. 2017 Dec 23;8(1):3. doi: 10.3390/brainsci8010003. Brain Sci. 2017. PMID: 29295472 Free PMC article.
-
Maternal spontaneous abortion and the risk of attention-deficit/hyperactivity disorder in offspring: a population-based cohort study.Hum Reprod. 2020 May 1;35(5):1211-1221. doi: 10.1093/humrep/deaa035. Hum Reprod. 2020. PMID: 32340041
-
Association Between Prenatal Acetaminophen Exposure and Future Risk of Attention Deficit/Hyperactivity Disorder in Children.Ann Pharmacother. 2015 Dec;49(12):1357-61. doi: 10.1177/1060028015606469. Epub 2015 Sep 23. Ann Pharmacother. 2015. PMID: 26400006 Review.
-
Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review.Lancet Psychiatry. 2020 Nov;7(11):955-970. doi: 10.1016/S2215-0366(20)30312-6. Lancet Psychiatry. 2020. PMID: 33069318
Cited by
-
The relationship of prenatal acetaminophen exposure and attention-related behavior in early childhood.Neurotoxicol Teratol. 2024 Jan-Feb;101:107319. doi: 10.1016/j.ntt.2024.107319. Epub 2024 Jan 8. Neurotoxicol Teratol. 2024. PMID: 38199313 Free PMC article.
-
Maternal and cord plasma branched-chain amino acids and child risk of attention-deficit hyperactivity disorder: a prospective birth cohort study.J Child Psychol Psychiatry. 2021 Jul;62(7):868-875. doi: 10.1111/jcpp.13332. Epub 2020 Sep 22. J Child Psychol Psychiatry. 2021. PMID: 32960988 Free PMC article.
-
Can biomarkers be used to diagnose attention deficit hyperactivity disorder?Front Psychiatry. 2023 Mar 8;14:1026616. doi: 10.3389/fpsyt.2023.1026616. eCollection 2023. Front Psychiatry. 2023. PMID: 36970271 Free PMC article. Review.
-
Early Life Origins of Neurodevelopmental Disabilities in the Boston Birth Cohort: Research findings and future directions.Precis Nutr. 2024 Mar;3(1):e00062. Epub 2024 Mar 8. Precis Nutr. 2024. PMID: 39184946 Free PMC article.
-
Long-Term Safety of Prenatal and Neonatal Exposure to Paracetamol: A Systematic Review.Int J Environ Res Public Health. 2022 Feb 14;19(4):2128. doi: 10.3390/ijerph19042128. Int J Environ Res Public Health. 2022. PMID: 35206317 Free PMC article.
References
-
- Pastor P.N., Duran C., Reuben C. Quickstats: Percentage of children and adolescents aged 5-17 years with diagnosed attention-deficit/hyperactivity disorder (adhd), by race and hispanic ethnicity—National health interview survey, United States, 1997–2014. Morb. Mortal. Wkly. Rep. 2015;64:925.
-
- Danielson M.L., Bitsko R.H., Ghandour R.M., Holbrook J.R., Kogan M.D., Blumberg S.J. Prevalence of parent-reported adhd diagnosis and associated treatment among U.S. Children and adolescents, 2016. J. Clin. Child Adolesc. Psychol. 2018;47:199–212. doi: 10.1080/15374416.2017.1417860. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources